Full name
PROGLIKEMIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
PROGLIKEMIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. SKIERNIEWICKA 16 / 20, 01-230 WARSZAWA
TAX ID5223105454
Rate company:
PROGLIKEMIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5223105454
KRS0000704941
Share capital50,000.00 zł
address
UL. SKIERNIEWICKA 16 / 20, 01-230 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5223105454
REGON
368795023
KRS
0000704941
Legal form
limited liability company
Register Address
UL. SKIERNIEWICKA 16 / 20, 01-230 WARSZAWA
Date of registration in KRS
2017-11-21
Date of commencement of economic activity
2017-11-21
Act signature
WA.XIII NS-REJ.KRS/23882/25/422
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
60.39.Z - Other content distribution activities
63.92.Z - Other information-related services
73.12.Z - Advertising through mass media
82.92.Z - Packaging activities
82.99 - Other business support activities, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
85.59.D - Other non-school forms of education, not classified elsewhere
Payer VAT status
Active
Vat list bank account(s)
PL59 1140 1010 0000 3895 7700 1002 
PL32 1140 1010 0000 3895 7700 1003 PL86 1140 1010 0000 3895 7700 1001 PL05 1140 1010 0000 3895 7700 1004 Show more bank accounts from VAT list (1)
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0,7 | 1,6 | 5 | 216,2 |
EBITDA | 0,6 | 1,7 | 6,2 | 258,3 |
Short time liabilities | 2,2 | 3,2 | 5,2 | 62,5 |
Equity capital | 0,4 | 1,4 | 3,9 | 181,8 |
Operating profit (EBIT) | 0,6 | 1,7 | 6,2 | 259,5 |
Assets | 2,7 | 4,8 | 9,4 | 97,2 |
Net profit (loss) | 0,6 | 1,5 | 4,7 | 217,8 |
Cash | 1,1 | 0,6 | 4,2 | 567,9 |
Net income from sale | 15,5 | 27,4 | 42,7 | 55,7 |
Liabilities and provisions for liabilities | 2,3 | 3,4 | 5,5 | 62,9 |
Working assets | 2,7 | 4,7 | 9,3 | 96,9 |
Depreciation | 0 | 0 | 0 | 92,7 |
% | % | % | p.p. | |
Profitability of capital | 140,9 | 107,8 | 121,6 | 13,8 |
Equity capital to total assets | 15 | 28,9 | 41,3 | 12,4 |
Gross profit margin | 4,6 | 5,8 | 11,8 | 6 |
EBITDA Margin | 4,1 | 6,3 | 14,5 | 8,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 53 | 42 | 44 | 2 |
Current financial liquidity indicator | 1.1684976816177368 | 1.400877833366394 | 1.6941066980361938 | 0,3 |
Net dept to EBITDA | -1.6243425607681274 | -0.35901233553886414 | -0.6748303771018982 | -0,3 |
Financial statements
01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
HS Medical Poland
Tychy
Red Shirt Barber
Warszawa
Cannabis Sklep
Świętochłowice, woj. śląskie, Polska
Katarzyna Poleszak
Toruń
EUR-MED POLSKA
Katowice
Przedsiębiorstwo Trans-Med
Zawiercie